LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF

The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation. 本发明提供新颖抗LILR抗体、包含此类抗体的药物组合物和使用此类抗体和药物组合物来治疗例如癌症、自身免疫性疾病或过敏性炎症的疾病的治疗方法。